文献速递儿科影像骨肌技术与安全PETMR

2-[18F]FDG-PET与全身弥散加权MRI检测儿童及年轻成人骨髓转移的诊断准确性

Diagnostic Accuracy of 2-[18F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults.
PubMed 文献 · Eur Radiol · 2022-01-31

该单中心横断面研究纳入23例儿童及年轻成人实体恶性肿瘤患者,共925处骨髓转移灶、66次同步2-[18F]FDG-PET与DW-MRI扫描,比较两种方法检测骨髓转移的诊断准确性。PET与DW-MRI联合诊断准确性为100.0%,显著高于单独PET(96.9%,p < 0.001)或单独DW-MRI(96.3%,p < 0.001)。

要点

  • 2-[18F]FDG-PET漏诊亚厘米病灶,DW-MRI漏诊小骨病灶,两者盲区不同。
  • 联合2-[18F]FDG-PET/MRI诊断准确性100.0%,高于单独任一方法。
  • 单独PET与DW-MRI特异度均为100%,但敏感度均未达100%。

核心结论

  • 2-[18F]FDG-PET与DW-MRI均可漏诊骨髓转移,两者联合可显著检出更多病灶。

研究设计与样本

  • 单中心横断面研究,纳入23例儿童及年轻成人(平均年龄16.8岁±5.1,范围7-25岁;16男7女),共66次同步2-[18F]FDG-PET与DW-MRI扫描(23次基线、43次化疗后随访),以骨髓活检和随访影像为标准参考。

关键影像表现/征象

  • 2-[18F]FDG-PET漏诊亚厘米病灶,DW-MRI漏诊小骨病灶,两者盲区不同。
  • 2-[18F]FDG-PET检出884/925处(95.5%)骨髓转移灶,DW-MRI检出893/925处(96.5%)骨髓转移灶。

诊断标准与关键数值

  • 2-[18F]FDG-PET诊断骨髓转移的敏感度91.0%、特异度100%。
  • DW-MRI诊断骨髓转移的敏感度89.1%、特异度100.0%。
  • 联合2-[18F]FDG-PET/MRI诊断骨髓转移的敏感度100.0%、特异度100.0%。
  • 联合2-[18F]FDG-PET/MRI诊断准确性100.0%,高于单独2-[18F]FDG-PET的96.9%(p < 0.001)和单独DW-MRI的96.3%(p < 0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the diagnostic accuracy of 2-[18F]fluoro-2-deoxy-D-glucose-enhanced positron emission tomography (2-[18F]FDG-PET) and diffusion-weighted magnetic resonance imaging (DW-MRI) for the detection of bone marrow metastases in children and young adults with solid malignancies.

METHODS: In this cross-sectional single-center institutional review board-approved study, we investigated twenty-three children and young adults (mean age, 16.8 years ± 5.1 [standard deviation]; age range, 7-25 years; 16 males, 7 females) with 925 bone marrow metastases who underwent 66 simultaneous 2-[18F]FDG-PET and DW-MRI scans including 23 baseline scans and 43 follow-up scans after chemotherapy between May 2015 and July 2020. Four reviewers evaluated all foci of bone marrow metastasis on 2-[18F]FDG-PET and DW-MRI to assess concordance and measured the tumor-to-bone marrow contrast. Results were assessed with a one-sample Wilcoxon test and generalized estimation equation. Bone marrow biopsies and follow-up imaging served as the standard of reference.

RESULTS: The reviewers detected 884 (884/925, 95.5%) bone marrow metastases on 2-[18F]FDG-PET and 893 (893/925, 96.5%) bone marrow metastases on DW-MRI. We found different "blind spots" for 2-[18F]FDG-PET and MRI: 2-[18F]FDG-PET missed subcentimeter lesions while DW-MRI missed lesions in small bones. Sensitivity and specificity were 91.0% and 100% for 18F-FDG-PET, 89.1% and 100.0% for DW-MRI, and 100.0% and 100.0% for combined modalities, respectively. The diagnostic accuracy of combined 2-[18F]FDG-PET/MRI (100.0%) was significantly higher compared to either 2-[18F]FDG-PET (96.9%, p < 0.001) or DW-MRI (96.3%, p < 0.001).

CONCLUSIONS: Both 2-[18F]FDG-PET and DW-MRI can miss bone marrow metastases. The combination of both imaging techniques detected significantly more lesions than either technique alone.

KEY POINTS: • DW-MRI and 2-[18F]FDG-PET have different strengths and limitations for the detection of bone marrow metastases in children and young adults with solid tumors. • Both modalities can miss bone marrow metastases, although the "blind spot" of each modality is different. • A combined PET/MR imaging approach will achieve maximum sensitivity and specificity for the detection of bone marrow metastases in children with solid tumors.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Rashidi, Baratto, Theruvath, et al. Diagnostic Accuracy of 2-[18F]FDG-PET and whole-body DW-MRI for the detection of bone marrow metastases in children and young adults. Eur Radiol. 2022. PMID: 35099603. doi:10.1007/s00330-021-08529-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。